Ozempic Trial Shows Drug Turns People Off Alcohol
Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.
Ozempic shown to reduce drinking in first trial in alcohol-use disorder
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just curb their desire to eat; for some, they also lead them to drink less alcohol.
Ozempic 'Significantly' Lowered 'Alcohol Craving' in First Clinical Trial, with Those Taking the Drug Drinking 40% Less
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of alcohol consumed when someone on the drug does drink
Weight loss drug semaglutide may reduce alcohol cravings, heavy drinking and smoking, new study finds
Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less alcohol.
Low-dose semaglutide reduces alcohol consumption and cravings in early trial
Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.
Semaglutide Cuts Alcohol Cravings in New Trial
A new clinical trial suggests that once-weekly semaglutide may reduce alcohol consumption and cravings in adults with alcohol use disorder.
Ozempic can curb alcohol cravings, study finds
Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and consumption in a small trial involving people with moderate alcohol use disorder,
Ozempic Users Are Drinking Less Alcohol Without Even Trying
In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an unlikely source: a drug best known for treating diabetes and obesity. Semaglutide,
Hosted on MSN8d
Ozempic Now FDA-Approved for Kidney Disease-Here's What to Know
GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...
News Medical5d
What's Next for Semaglutide? Beyond Diabetes and Weight Loss
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Healio23d
Obesity medications can tackle metabolic cardiorenal disease
The FLOW trial of 3,533 patients is the first primary kidney trial with an incretin mimetic, semaglutide. Like CREDENCE, FLOW was conducted in adults with type 2 diabetes. Participants were ...
WebMD1d
Semaglutide Shows Promise for Cutting Alcohol Use
A clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to ...
Monthly Prescribing Reference18d
Ozempic Approval Expanded to Include T2D Patients With Chronic Kidney Disease
Credit: Novo Nordisk. The approval was based on data from the randomized, double-blind, placebo-controlled FLOW trial. Semaglutide reduced the risk of kidney disease worsening, renal failure ...
Medindia1d
Can Semaglutide Curb Alcohol Consumption and Heavy Drinking?
Semaglutide, used for diabetes and obesity, may reduce alcohol cravings in adults with alcohol use disorder, offering a potential solution to a major treatment gap.